Related Experiment Video
Updated: Sep 7, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Association between chronic kidney disease and mortality in patients with a confirmed COVID-19 diagnosis
Jacqueline Betsabe Puicón-Suárez1, Sandra Zeña-Ñañez2, Virgilio E Failoc-Rojas3,4
1Sociedad Científica de Estudiantes de Medicina, SOCIEM-UNPRG, Universidad Nacional Pedro Ruiz Gallo, Lambayeque, Perú.
Insights
Chronic kidney disease (CKD) significantly increases mortality risk for patients diagnosed with coronavirus disease 2019 (COVID-19). This risk is further elevated when CKD is combined with diabetes mellitus and hypertension.
Area of Science:
- Nephrology
- Infectious Diseases
- Epidemiology
Background:
- Chronic kidney disease (CKD) is a global health concern.
- Coronavirus disease 2019 (COVID-19) has emerged as a significant pandemic.
- Understanding the interplay between CKD and COVID-19 outcomes is crucial for patient management.
Purpose of the Study:
- To investigate the association between chronic kidney disease (CKD) and mortality in individuals diagnosed with coronavirus disease 2019 (COVID-19).
Main Methods:
- Cross-sectional secondary baseline study.
- Analysis of 243,065 patients diagnosed with COVID-19 between May and December 2020.
- Statistical analysis included Chi-square tests and Poisson regression with robust variances using Stata 16.0.
Main Results:
- Patients with COVID-19 and CKD exhibited a 1.42 times higher prevalence of mortality compared to those without CKD.
- The highest mortality probability was observed in patients with CKD comorbid with diabetes mellitus and hypertension.
- Comorbidities significantly amplified the mortality risk in COVID-19 patients with CKD.
Conclusions:
- Chronic kidney disease (CKD) is strongly associated with increased mortality rates in COVID-19 patients.
- The combination of CKD, diabetes mellitus, and arterial hypertension presents a significantly higher mortality risk.
- Identifying and managing CKD in COVID-19 patients, especially those with diabetes and hypertension, is critical for improving survival rates.
Objective:
To determine the association between chronic kidney disease (CKD) and mortality in persons with a confirmed coronavirus disease 2019 (COVID-19) diagnosis.
Methods:
Cross-sectional secondary baseline study. The study population consisted of 243,065 patients confirmed to have COVID-19 during May-December 2020. Stata 16.0 was used for statistical analysis, Chi-square test was used for bivariate analysis, and Poisson regression with robust variances was used for multiple analysis.
Results:
The prevalence of patients with a confirmed COVID-19 diagnosis who had CKD and died was 1.42 times the prevalence of mortality in those without CKD. The comorbidities combined with CKD that presented the highest probability of mortality were diabetes mellitus and hypertension.
Conclusions:
CKD is associated with a high mortality rate in patients with a confirmed COVID-19 diagnosis. Patients with CKD, diabetes mellitus, and arterial hypertension have a higher prevalence of mortality than those without comorbidities.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology

